Findikli N, Candan N Z, Kahraman S
Istanbul Memorial Hospital ART and Reproductive Genetics Centre, Istanbul, Turkey.
Reprod Biomed Online. 2006 Oct;13(4):581-90. doi: 10.1016/s1472-6483(10)60648-7.
Embryonic stem cells (ESC) are multipotent cells isolated from blastocyst-stage preimplantation embryos. Since their first culture in 1998, human ESC have revolutionized reproductive and regenerative medicine by allowing the establishment of detailed molecular and therapeutic models for certain metabolic pathways and life-threatening disorders. They also offer significant contributions to genetics and pharmacology in designing and analysing disease models that can be closer to in vivo than any other procedures available. However, the procedures by which they are obtained and manipulated also create intense ethical and social debates worldwide. This article discusses the current limitations and recent advances in isolation, culture and differentiation of human ESC from the laboratory perspective.
胚胎干细胞(ESC)是从囊胚期植入前胚胎中分离出来的多能细胞。自1998年首次培养以来,人类胚胎干细胞通过为某些代谢途径和危及生命的疾病建立详细的分子和治疗模型,彻底改变了生殖医学和再生医学。它们还为遗传学和药理学做出了重大贡献,设计和分析比其他任何现有程序更接近体内情况的疾病模型。然而,获取和操作它们的程序也在全球范围内引发了激烈的伦理和社会辩论。本文从实验室角度探讨了人类胚胎干细胞分离、培养和分化方面的当前局限性和最新进展。